 |
1 Product |  |
0 Diseases | | 1 Product |
|
0 Trials |  |
7 News |  |
- | APD-209 / Adenovir
Trial completion, Enrollment change, Trial primary completion date: Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) (clinicaltrials.gov) - Nov 2, 2016
P2, N=47, Completed, Sponsor: Adenovir Pharma AB
Recruiting --> Completed | N=130 --> 47 | Trial primary completion date: Dec 2016 --> Sep 2016
- || APD-209 / Adenovir
Trial primary completion date: Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) (clinicaltrials.gov) - Jan 22, 2016
P2, N=130, Recruiting, Sponsor: Adenovir Pharma AB
Recruiting --> Completed | N=130 --> 47 | Trial primary completion date: Dec 2016 --> Sep 2016 Trial primary completion date: Dec 2015 --> Dec 2016
- || APD-209 / Adenovir
Trial primary completion date: Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) (clinicaltrials.gov) - May 1, 2015
P2, N=130, Recruiting, Sponsor: Adenovir Pharma AB
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jul 2015 --> Dec 2015
- || APD-209 / Adenovir
Trial primary completion date: Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) (clinicaltrials.gov) - Jan 15, 2015
P2, N=130, Recruiting, Sponsor: Adenovir Pharma AB
Trial primary completion date: Jul 2015 --> Dec 2015 Trial primary completion date: May 2014 --> Jul 2015
- |||| APD-209 / Adenovir
Enrollment open: Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) (clinicaltrials.gov) - Nov 13, 2013
P2, N=130, Recruiting, Sponsor: Adenovir Pharma AB
Trial primary completion date: May 2014 --> Jul 2015 Not yet recruiting --> Recruiting
- ||||| APD-209 / Adenovir
New P2 trial: Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) (clinicaltrials.gov) - Nov 4, 2013
P2, N=130, Recruiting, Sponsor: Adenovir Pharma AB
- | formoterol/megestrol (APD209) / Eagle Pharma
Trial completion, Metastases: Pilot Study of APD209 in Cancer Cachexia (clinicaltrials.gov) - Jan 11, 2012
P2, N=13, Completed, Sponsor: Acacia Pharma Ltd
Not yet recruiting --> Recruiting Recruiting --> Completed